Company intelligence / Profile preview

Therus

Bothell, Washington, USA

Ownership: Private
Development stage: Other

Overview

Therus Corporation was a medical device company that developed non-invasive technology for vascular closure following catheterization procedures. The company's primary product was a system utilizing High Intensity Focused Ultrasound (HIFU) to seal femoral artery punctures without the need for implanted materials or manual compression. By delivering localized acoustic energy, the device induced rapid thermal coagulation of the tissue to achieve hemostasis. Therus was acquired by Boston Scientific in 2005 to integrate its ultrasound-guided closure technology into their interventional cardiology and radiology portfolios.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Therus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Therus.

Explore the full profile